Study to Assess the Benefits of Aktiia Blood Pressure Monitoring for Early Detection of Hypertension and Cardiovascular Risk in Adults Ages 21 to 85 in Europe

What this Trial Is About

This research evaluates the clinical benefits of the Aktiia Blood Pressure Monitoring system for early detection of hypertension and predicting cardiovascular risk. The study involves a multi-ethnic European population and aims to correlate continuous blood pressure monitoring with environmental and health factors over time to improve hypertension management. It is an observational study sponsored by Aktiia SA. Participants are divided into three groups those who already own the Aktiia G1 device with Android smartphones, those with iOS smartphones, and individuals without the Aktiia G1 device but owning either iOS or Android smartphones. Over the next 10 years, participants who own the Aktiia G1 device will wear it continuously. All participants will complete online surveys about their lifestyle, health, and socioeconomic environment every six months. Additionally, once available, participants will use the Aktiia One App to take on-demand fingertip blood pressure measurements using the smartphone camera. During the study, participants will be monitored through continuous blood pressure data from the Aktiia G1 device and periodic surveys. The main outcome measured is how continuous blood pressure monitoring relates to sociodemographic, lifestyle, and health factors over 10 years. Secondary outcomes include projections of benefits from early hypertension awareness using the fingertip measurement feature. Participants engage in regular surveys and on-demand blood pressure checks, with the study lasting up to 10 years.

Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk